Newton Biocapital — Full Portfolio

DeuterOncology is a clinical-stage biotech developing DO-2, a deuterated, brain-penetrant MET kinase and RAS pathway inhibitor for cancer patients, currently in a phase 1 clinical study.

BiotechHealthtechMedical DevicesLiege, BE

Timothy Perera(Founder & CEO)in

Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders.

BiotechDeep TechHealthtechMedical Devices

BVBenoit Vanhollebeke(Scientific Founder)inDBDenis Bedoret(Executive Director)in

Co-investorsSASambrinvestWAWallonie Entreprendre

Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.

BiotechHealthtechMedical DevicesGhent, BE

Co-investorsBLBlackRockEQEQT Life SciencesKRKreos CapitalRORosetta Capital Ltd.VIVI PartnersBOBootstrap Europe+2 more

PRISM BioLab is a biotechnology company that develops PepMetics, a proprietary drug discovery platform of small molecules designed to mimic α-helix or β-turn peptides, aiming to target proteins previously considered "undruggable." The company maintains a screening library of over 20,000 compounds and partners with pharmaceutical firms on drug discovery programs.

AI & Machine LearningBiotechDeep TechTokyo, JP

Co-investorsDBDBJ CapitalEIEisai Innovation, Inc.

Acticor Biotech develops Glenzocimab, a therapeutic candidate targeting GPVI for treating acute ischemic stroke and STEMI.

BiotechDigital HealthMedical Devices

GAGilles AVENARD(Chief Executive Officer)

Co-investorsKAKaristaANAnaxagoGOGO Capital

AdipoPharma is a biotech company developing therapies based on the endocrine biology of adipose tissue and targeted rare genetic disorders.

BiotechHealthtechLongevityMedical DevicesStrasbourg, FR

VMVincent Marion(Founder)inCPCatherine Perot(Chief Financial Officer)inMJMichael J. Fare(Chief Operating Officer)inTGTarekegn G. Hiwot(Chief Medical Officer)

Co-investorsGOGood Growth Capital

Augustine Therapeutics is a biotech company developing HDAC6-targeted therapies for peripheral neuropathies such as Charcot-Marie-Tooth disease and chemotherapy-induced peripheral neuropathy, as well as neurodegenerative disorders like ALS.

BiotechMedical Devices

Co-investorsADAdBio partnersJEJeito CapitalNONovo HoldingsPMPMVV-V-Bio VenturesASAsabys Partners

Dim3 provides medical device software and hardware for clinical nutrition management, helping doctors, dietitians, and nurses detect malnutrition risks, plan personalized nutrition interventions, and track patient outcomes in real-time across healthcare settings.

Digital HealthHealthtechMedical Devices

EPICS Therapeutics develops RNA epigenetics-based cancer treatments, focusing on METTL3 inhibitors for cancers including non-small cell lung cancer, pancreatic cancer, ovarian cancer, and colorectal cancer where existing therapies are insufficient.

BiotechDigital HealthMedical Devices

Co-investorsFUFund+

Perseus Proteomics develops and supplies research antibodies targeting nuclear receptors and transcription factors, along with ELISA kits and diagnostic assays, serving life sciences researchers and pharmaceutical development.

BiotechDeep TechHealthtechMedical Devices

Co-investorsDBDBJ CapitalKYKyoto University Innovation CapitalNINippon Venture CapitalSMSMBC Venture Capital

Santero is a Belgium-based biotech company developing antibacterial drugs, including an RSH inhibitor programme targeting Pseudomonas aeruginosa and multidrug-resistant pathogens.

AI & Machine LearningBiotechDeep TechHealthtechBrussels, BE

AGAbel Garcia-Pino(Co-founder & Scientific Advisor)inCGCédric Govaerts(Co-founder & Scientific Advisor)inMBMark Beards(Chief Executive Officer)inEREmilie Racine(COO & Head of Chemistry)inCVCuong Vuong(Chief Scientific Officer)inValérie Gallien(Chief of Staff)in

Co-investorsSASambrinvest

Synergia Medical develops optoelectronic implantable medical devices, including its NAO.VNS vagus nerve stimulation system, which is undergoing First-In-Human clinical evaluation through the AURORA study.

Deep TechHealthtechMedical DevicesBrussels, BE

CNCharles Nolet(CEO)inVDVincent De Rudder(VP QARA)Gijs Klarenbeek(VP of Clinical)DSDan Scherrer(COO)inDimitri Crelot(CFO)in

Tensegrity Pharma develops early-stage clinical development programs and drug discovery services for the pharmaceutical industry.

BiotechDeep TechHealthtechMedical Devices

Takahito Nakahara(Founder, President & CEO)

EditForce develops proprietary PPR gene-editing technology that can modify both DNA and RNA, with applications in medicine, agriculture, and chemical industries.

AI & Machine LearningBiotechFukuoka, JP

小野 高(代表取締役社長 CEO)

Co-investorsGLGlobal BrainKDKDDI Open Innovation FundUTUTEC

J-Pharma is a drug development company focused on SLC transporter-targeted therapies, with its lead LAT1 inhibitor nanvuranlat (JPH203) in a global Phase 3 trial for biliary tract cancer and other candidates addressing cancer, autoimmune, and rare diseases.

BiotechDigital HealthHealthtechMedical DevicesTokyo, JP

�益𠮷武 益広(代表取締役社長 (Representative Director & President))藤裕藤本 裕(取締役CFO)山寛山本 寛(取締役CBO)

Co-investorsF-F-Prime CapitalOIOita Venture CapitalOSOSAKA University Venture CapitalSESeibu Shinkin CapitalUNUntroD Capital